FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes

NCT00743925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

625

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Varespladib Methyl (A-002)

Sponsor

Anthera Pharmaceuticals